Health care stocks leaned lower premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) fell by 0.2% and the iShares Biotechnology ETF (IBB) was down 0.1% recently.
ARS Pharmaceuticals (SPRY) shares advanced by over 4% after the company reported that it swung to 2024 earnings as revenue surged during the year.
Elevation Oncology (ELEV) shares were almost 36% lower after the company said it is dropping the development of EO-3021, an antibody-drug conjugate for the potential treatment of advanced, unresectable, or metastatic gastric and gastroesophageal junction cancers.
OptiNose (OPTN) shares were up more than 58% after the company overnight said it agreed to be acquired by Paratek Pharmaceuticals in a deal valued at up to $330 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.